1231038

Abdullah Mubarak, M.D. — FEI 3029954730

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
2272721 CFR 312.64(b)Safety Reports - Serious Events
756021 CFR 312.60FD-1572, protocol compliance